Digital Therapeutic
Top in cardiology: COVID-19 linked to increased CV risk; semaglutide improves HF symptoms
Researchers found that patients with a positive SARS-CoV-2 PCR test faced an increased risk for major adverse cardiac events vs. individuals without SARS-CoV-2; this risk was even higher among patients hospitalized for COVID-19.
VIDEO: ‘Clear lack of data’ on digital CV health tools for women concerning
In this Healio video exclusive, Sana M. Al-Khatib, MD, professor of medicine at Duke University School of Medicine, discusses barriers to developing cardiovascular digital health solutions for women.
Q&A: ‘Inclusive design’ needed if technology is to improve, not worsen, health disparities
Health care has experienced a wave of technological advancements — such as AI, machine learning and wearables — in recent years, but if unchecked, they may exacerbate existing disparities in treatment and care.
Prescription digital therapeutic reduces monthly migraine days, phase 3 study shows
A novel digital therapeutic for migraine prevention met its primary endpoint of reducing the number of monthly migraine days, according to results from a phase 3 clinical trial.
Prescription digital therapeutic for postpartum depression receives FDA 510(k) clearance
An 8-week prescription digital therapeutic for treatment of postpartum depression symptoms received FDA 510(k) clearance, according to a press release from Curio Digital Therapeutics.
FDA clears prescription digital therapeutic for adults with major depressive disorder
The FDA has cleared a first-of-its-kind prescription digital therapeutic to treat major depressive disorder symptoms as an adjunct to clinician-managed outpatient care in adults who have been prescribed antidepressants.
Partnership to advance digital biomarker platform for Parkinson’s disease
A Swiss-based medical technology company has announced a partnership with Biogen to advance a digital biomarker platform involved in a planned clinical trial for BIIB122, a novel therapeutic to treat Parkinson’s disease.
VIDEO: Several issues to consider before transitioning to digital operating room
FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Burkhard Dick, MD, PhD, offers practical advice on how to make the transition to a digital operating room.
FDA grants breakthrough device designation to digital therapeutic for schizophrenia
The FDA has granted breakthrough device designation for CT-155, an investigational prescription digital therapeutic co-developed by Click Therapeutics and Boehringer Ingelheim to treat negative symptoms of schizophrenia.
The Development of GI Psychology with Megan Riehl, PsyD
In this podcast episode, Megan Riehl, PsyD, discusses symptoms and solutions in GI psychology, building educational tools for patients and physicians on GI psychology and more.